Today's Top Health News Story

Britain's use of copycat biotech drugs takes off while U.S. lags

LONDON (Reuters) - Cut-price copies of an expensive Roche biotech drug for blood cancer have taken 80 percent of the British market since launching last year, saving the healthcare system 80 million pounds ($113 million) a year, experts said on Wednesday. Learn More


More Top Health Stories

Scientists develop brain scanner in a helmet

(Reuters) - British scientists have developed a lightweight and highly sensitive brain imaging device that can be worn as a helmet, allowing the patient to move about naturally. More »


U.S. infant mortality high even for full-term babies

(Reuters Health) - Infant mortality rates for full-term babies vary across the U.S., but all states are worse than many European countries, a new study suggests. More »


Longtime U.S. AIDS researcher picked to run CDC

CHICAGO (Reuters) - Longtime AIDS researcher Dr. Robert Redfield will be the new director of the Centers for Disease Control and Prevention in Atlanta, the administration of U.S. President Donald Trump announced on Wednesday. More »


Gluten-free diet may still allow harmful levels of exposure

(Reuters Health) - Carefully following a gluten-free diet might not protect people with celiac disease from exposure to potentially harmful amounts of gluten, new findings suggest. More »


GlaxoSmithKline prescribes commercial reboot for pharma division

LONDON (Reuters) - In January, GlaxoSmithKline's new head of pharmaceuticals Luke Miels issued a blunt challenge to his managers: find budget savings of 20 percent. More »


Shoe inserts may not help plantar heel pain

(Reuters Health) - Mass-produced shoe inserts available on drugstore shelves and customized orthotics may not work for plantar heel pain, a research review suggests. More »


Germany confirms H5N6 bird flu case on island farm

HAMBURG (Reuters) - German authorities have confirmed outbreak of the highly pathogenic H5N6 bird flu type at a farm on an island off the German North Sea coast, the Schleswig-Holstein state agriculture ministry said on Wednesday. More »


Endo, others to pay $270.8 mln to resolve Lidoderm U.S. antitrust cases

(Reuters) - Endo International Plc and two other companies have agreed to pay $270.8 million to resolve class action lawsuits alleging Endo paid a generic drug manufacturer to delay launching a cheaper version of its Lidoderm painkiller patch. More »


Childhood `toxic stress’ leads to parenting challenges later on

Reuters Health - Parents who endured “toxic stress” during childhood may be more likely to have kids with developmental delays and have a harder time coping with their children’s health issues, new research suggests. More »


News, Photo and Web Search